DBDebanjan Bhowmik

Debanjan Bhowmik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Debanjan Bhowmik has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Selective detection of membrane-bound amyloid-β oligomers using SERS “hot-spots”: toward early diagnostics for Alzheimer's disease

    by Abhirami Ajith, Sudhanshu Mani Tripathi, Poornendhu Jayasree, Harikrishnan K. Surendran, Mekhla Chowdhury, Atasi Ghanti, Chandrabhas Narayana, Debanjan Bhowmik

    Lipid-coated AgNPs capture lipophilic Aβ oligomers, which are selectively detected by Rose Bengal-functionalized AgNPs through SERS originating from AgNP-proximity-induced plasmonic hot spots.


  • Open Access

    Hypertrophic cardiomyopathy mutations Y115H and E497D disrupt the folded-back state of human β-cardiac myosin allosterically

    by Neha Nandwani, Debanjan Bhowmik, Camille Glaser, Matthew Carter Childers, Rama Reddy Goluguri, Aminah Dawood, Michael Regnier, Anne Houdusse, James A. Spudich, Kathleen M. Ruppel

    At the molecular level, clinical hypercontractility associated with many hypertrophic cardiomyopathy (HCM)-causing mutations in β-cardiac myosin appears to be driven by their disruptive effect on the energy-conserving, folded-back ‘OFF’-state of myosin, which results in increased number of heads free to interact with actin and produce force. While many characterized mutations likely act by directly perturbing intramolecular interfaces stabilizing the OFF-state, others may function allosterically by altering conformational states of the myosin motor. We investigate two such allosteric HCM mutations, Y115H (Transducer) and E497D (Relay helix), which do not directly contact OFF-state interfaces. Biochemical analyses and high-resolution crystallography reveal that both mutations increase active myosin head availability likely by destabilizing the pre-powerstroke conformation required for OFF-state formation. We propose that destabilization of the folded-back state of myosin, either directly or allosterically, represents a common molecular mechanism underlying hypercontractility in HCM across a broader spectrum of pathogenic mutations than previously recognized.


  • Optimizing Branch Morphology in Gold Nanostars To Improve HER2-Targeted Cytotoxicity in HER2-Overexpressing Cancer Cells in the Presence of Serum Proteins

    by Irfan Shafi Malik, Nithya K. Nair, Athira B, Shambhavi Mishra, Shreya Unnithan, Chandrabhas Narayana, Debanjan Bhowmik

    Gold nanoparticles (AuNPs) have demonstrated significant potential for targeted imaging and drug delivery. However, their effectiveness may be compromised by the nonspecific adsorption of serum proteins, forming a protein corona that traps surface ligands and interferes with receptor targeting. This study investigates the impact of the branch morphology of anti-HER2 aptamer-functionalized gold nanostars (AuNS) on their ability to exert cytotoxicity in human epidermal growth factor receptor 2 (HER2)-overexpressing cancer cells in the presence of serum proteins. By controlling reaction kinetics using temperature in HEPES-mediated seeded-AuNS synthesis, we produced homogeneous populations of AuNS with varying branch lengths but comparable hydrodynamic sizes and concentrations. Transmission electron microscopy (TEM) revealed that longer and sharper branches on aptamer-functionalized AuNS were significantly more effective at avoiding sequestration by the protein corona than shorter branches. Subsequently, HER2-targeting AuNS with longer branches caused significantly greater cytotoxic effects in HER2-overexpressing SKOV3 cancer cells than did AuNPs with spheroidal morphologies. The differences in the cytotoxic effect caused by spheroidal AuNPs and AuNS with shorter branches were statistically insignificant. These findings underscore the importance of optimizing the AuNS branch morphology for improved receptor-specific drug delivery and targeted cancer therapies, offering valuable insights into nanomedicine design.


  • Open Access

    Exploring breast cancer-related biochemical changes in circulating extracellular vesicles using Raman spectroscopy

    by Arianna Bonizzi, Lorena Signati, Maria Grimaldi, Marta Truffi, Francesca Piccotti, Stella Gagliardi, Giulia Dotti, Serena Mazzucchelli, Sara Albasini, Roberta Cazzola, et al.


  • Open Access

    Exploring Breast Cancer-Related Biochemical Changes in Circulating Extracellular Vesicles Using Raman Spectroscopy

    by Arianna Bonizzi, Lorena Signati, Maria Grimaldi, Marta Truffi, Francesca Piccotti, Stella Gagliardi, Giulia Dotti, Serena Mazzucchelli, Sara Albasini, Roberta Cazzola, et al.

    Extracellular vesicles (EVs) are a subgroup of the circulating particles, released by cells in both normal and diseased states, carrying active biomolecules. They have gained significant attention as potential cancer biomarkers, particularly in breast cancer (BC). Previous research showed variations in EVs content and quantity between BC patients and healthy controls (HC). However, studying EVs biochemical profile remains challenging due to their low abundance and complex composition. Additionally, EVs may interact with other plasma components, like lipoproteins (LPs), forming a so called “biomolecular corona” that further complicates their analysis. Here, Raman spectroscopy (RS) is proposed as a fast tool to obtain the biochemical profile of circulating EVs in the context of BC. RS was employed to differentiate various extracellular particles (EPs) in blood, including LPs and EVs. The study also evaluated RS’s capability to quantify major classes of biomolecules and compared these results with those obtained by traditional biochemical assays. Finally, compositional differences in large EVs (lEVs) and small EVs (sEVs) were assessed between 30 HC and 34 BC patients. RS revealed the existence of distinct biochemical signatures associated with BC, highlighting increased levels of nucleic acids and lipids in the BC group.

  • Open Access

    Hypertrophic cardiomyopathy mutations Y115H and E497D disrupt the folded-back state of human beta-cardiac myosin allosterically

    by Neha Nandwani, Debanjan Bhowmik, Matthew Carter Childers, Rama Reddy Goluguri, Aminah Dawood, Michael Regnier, James A Spudich, Kathleen M. Ruppel

    At the molecular level, clinical hypercontractility associated with many hypertrophic cardiomyopathy (HCM)-causing mutations in β-cardiac myosin appears to be driven by their disruptive effect on the energy-conserving, folded-back, super relaxed (SRX) ‘OFF’-state of myosin. A pathological increase in force production results from release of heads from this ‘OFF’-state, which results in an increase in the number of heads free to interact with actin and produce force. Pathogenic mutations in myosin can conceivably disrupt the ‘OFF’-state by (1) directly affecting the intramolecular interfaces stabilizing the folded-back state, or (2) allosterically destabilizing the folded-back state via disruption of diverse conformational states of the myosin motor along its chemomechanical cycle. However, very little is understood about the mutations that fall in the latter group. Here, using recombinant human β-cardiac myosin, we analysed the biomechanical properties of two such HCM-causing mutations, Y115H (in the transducer) and E497D (in the relay helix), neither of which falls in the regions that interact to stabilize myosin’s folded-back state. We find these mutations have diverse effects on the contractility parameters of myosin, yet the primary hypercontractile change in both cases is the destabilization of the ‘OFF’-state of myosin and increased availability of active myosin heads for actin-binding. Experimental data and molecular dynamics simulations indicate that these mutations likely destabilize the pre-powerstroke state of myosin, the conformation the motor adopts in the inactive folded-back state. We propose that destabilization of the folded-back state of myosin, directly and/or allosterically, is the molecular basis of hypercontractility in HCM in a far greater number of pathogenic mutations than currently thought.


  • Open Access

    Hypertrophic cardiomyopathy mutations in the pliant and light chain-binding regions of the lever arm of human β-cardiac myosin have divergent effects on myosin function

    by Makenna M. Morck, Debanjan Bhowmik, Aminah Dawood, James A. Spudich, Kathleen M. Ruppel

    Mutations in the lever arm of β-cardiac myosin are a frequent cause of hypertrophic cardiomyopathy (HCM), a disease characterized by hypercontractility and eventual hypertrophy of the left ventricle. Here, we studied five such mutations: three in the pliant region of the lever arm (D778V, L781P, and S782N) and two in the light chain-binding region (A797T and F834L). We investigated their effects on both motor function and myosin S2 tail-based autoinhibition. The pliant region mutations had varying effects on the motor function of a myosin construct lacking the S2 tail: overall, D778V increased power output, L781P reduced power output, and S782N had little effect on power output, while all three reduced the external force sensitivity of the actin detachment rate. With a myosin containing the motor domain and the proximal S2 tail, the pliant region mutations also attenuated autoinhibition in the presence of filamentous actin but had no impact in the absence of actin. By contrast, the light chain-binding region mutations had little effect on motor activity but produced marked reductions in autoinhibition in both the presence and absence of actin. Thus, mutations in the lever arm of β-cardiac myosin have divergent allosteric effects on myosin function, depending on whether they are in the pliant or light chain-binding regions.


  • Lattice-Resonance Metalenses for Fully Reconfigurable Imaging

    by Jingtian Hu, Danqing Wang, Debanjan Bhowmik, Tingting Liu, Shikai Deng, Michael P. Knudson, Xianyu Ao, Teri W. Odom

    This paper describes a reconfigurable metalens system that can image at visible wavelengths based on arrays of coupled plasmonic nanoparticles. These lenses manipulated the wavefront and focused light by exciting surface lattice resonances that were tuned by patterned polymer blocks on single- particle sites. Predictive design of the dielectric nano-blocks was performed using an evolutionary algorithm to create a range of 3D focusing responses. For scalability, we demonstrated a simple technique for erasing and writing the polymer nanostructures on the metal nanoparticle arrays in a single step using solvent assisted nanoscale embossing. This reconfigurable materials platform enables tunable focusing with diffraction-limited resolution and offers prospects for highly adaptive, compact-imaging.